TrialAntimicrobial agents and chemotherapy2011

Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.

Lala M Dunbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.